Market News AIOpen the app

Compass Therapeutics has been warned that its stock price has stayed below $1.00 for 30 days, risking its listing.

TroubleRead the original at SEC EDGAR
Bad for CMPX

CMPX's bid price stayed below Nasdaq's $1.00 rule for 30 business days, putting its listing at risk. It remains listed and has 180 days to meet the rule, but that deadline does not erase the risk.

CMPX · Compass Therapeutics, Inc.

AI read · Bad for CMPX

The AI's read

Losing its Nasdaq listing could make CMPX shares harder to trade and weaken confidence in the company. The warning does not remove CMPX from Nasdaq now. It has until May 18, 2027, and may qualify for another 180 days, but the filing says success is not assured.

Get alerts for CMPX

Follow Compass Therapeutics, Inc. (CMPX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CMPX
Free on the App Store and Google Play, or on the web.